Active surveillance cost effective for low-risk prostate cancer Clinical study 12 January 2019 Pages: 3 - 3
Addressing uncertainty in cost-effectiveness case for lenalidomide Clinical study 12 January 2019 Pages: 4 - 4
Antibiotic prophylaxis cost saving in elective cesarean section Clinical study 12 January 2019 Pages: 6 - 6
Betrixaban for VTE prophylaxis: better outcomes, lower cost Clinical study 12 January 2019 Pages: 10 - 10
CAR-T cell therapy cost effective for paediatric B-cell ALL? Clinical study 12 January 2019 Pages: 13 - 13
Checklist use inconsistent in reviews of economic evaluations Clinical study 12 January 2019 Pages: 14 - 14
COME HOME program reduces Medicare expenditure and ED visits Clinical study 12 January 2019 Pages: 15 - 15
Continuity in primary care associated with cost reductions Non-clinical study 12 January 2019 Pages: 16 - 16
Do insurance mandates ease burden for children with autism? Clinical study 12 January 2019 Pages: 18 - 18
Doxycycline + prednisolone cost effective in COPD exacerbation? Clinical study 12 January 2019 Pages: 19 - 19
Genomic Prostate Score good value for guiding treatment Clinical study 12 January 2019 Pages: 22 - 22
Lenalidomide cost effective in newly diagnosed multiple myeloma Clinical study 12 January 2019 Pages: 24 - 24
Nivolumab not cost effective in advanced NSCLC in Australia Clinical study 12 January 2019 Pages: 26 - 26
Opioids double treatment costs in degenerative joint disease Clinical study 12 January 2019 Pages: 27 - 27
Patient navigation increases colonoscopy screening, saves cost Clinical study 12 January 2019 Pages: 28 - 28
Rivaroxaban after PCI in AF: better outcomes, lower cost Clinical study 12 January 2019 Pages: 29 - 29
Sequencing for maturity-onset diabetes of the young cost saving Clinical study 12 January 2019 Pages: 30 - 30
Telemedicine follow-up in liver transplant recipients viable option Clinical study 12 January 2019 Pages: 31 - 31
Undesignated stock epinephrine in schools cost effective Clinical study 12 January 2019 Pages: 33 - 33
ICER considers biologicals low value for uncontrolled asthma News item 12 January 2019 Pages: 34 - 34
NICE recommends lenvatinib for untreated advanced liver cancer News item 12 January 2019 Pages: 38 - 38